KSIH yields 20000.00% · JNJ yields 2.13%● Live data
📍 KSIH pulled ahead of the other in Year 1
Combined, KSIH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KSIH + JNJ for your $10,000?
KS International Holdings Corporation focuses on providing solutions and services to individuals seeking to become Internet-based retailers. It operates a Web site, kachingkaching.com, which provides individual Web Store owners with the ability to create, manage, and earn money from product sales generated from their individual online Web stores. The company provides Web Store owners with solutions and resources necessary to create, design, and maintain a Web Store; access to a range of retail goods at competitive prices; and order fulfillment, customer service, and other back-office functions, which assist Web Store Owners with tracking and managing orders and sales from their Web Stores. Its store products include books, DVDs, computers, software, kitchen products, home and garden products, pet supplies, cosmetics and fragrance products, health and wellness products, consumer electronics, cameras, and office supplies. The company was formerly known as KaChing KaChing, Inc. and changed its name to KS International Holdings Corporation in December 2013. KS International Holdings Corporation was founded in 2009 and is headquartered in Taipei City, Taiwan.
Full KSIH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.